Related Experiment Video
Updated: Apr 23, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Aspects of metabolic changes in first-episode drug-naïve schizophrenic patients
Marat G Uzbekov1, Eduard Misionzhnik1, Isaak Gurovich2
11 Department of Brain Pathology, Research Institute of Psychiatry, Moscow, Russia.
Unlabelled:
Aim The aim of the study was to investigate the state of parameters characterising different sites of metabolism and the degree of endogenous intoxication in first-episode drug-naïve schizophrenic [first episode of schizophrenia (FES)] patients. It is hypothesised that the FES is the initial step in the development of pathologically disturbed biochemical status that is characteristic of chronic schizophrenia.
Methods:
Platelet monoamine oxidase (MAO) and serum semicarbazide-sensitive amine oxidase (SSAO) activities, serum concentrations of middle-mass endotoxic molecules (MMEM) and malondialdehyde and parameters of the serum albumin functional state were measured in 26 FES patients and 15 age-matched healthy controls.
Results:
Severity of disorder before the treatment was 75.5 ± 2.2, according to Positive and Negative Syndrome Scale score. FES patients were characterised by significant increase in MAO activity (99%) and MMEM concentration (124%) and significant decrease in SSAO activity (26%) as compared with controls. Changes of all other parameters were insignificant. Regression analysis has showed a significant relationship of three parameters - MAO, SSAO and MMEM, with values of PANNS score. Two methods of extraction of factor analysis revealed that MAO and SSAO belonged to Factor 1, whereas MMEM and albumin functional parameters belonged to Factor 2.
Conclusion:
Comparing our earlier data on chronic schizophrenic patients with present data, we hypothesise that FES patients are at the stage that leads to a stable, pathological state of metabolism.
Insights
First-episode drug-naïve schizophrenic patients show altered metabolism and increased endogenous intoxication. These findings suggest schizophrenia
Area of Science:
- Biochemistry
- Psychiatry
- Metabolic Disorders
Background:
- Schizophrenia is a complex psychiatric disorder with debated underlying biochemical mechanisms.
- Early stages of schizophrenia may present distinct metabolic profiles compared to chronic forms.
Purpose of the Study:
- To investigate metabolic parameters and endogenous intoxication in first-episode drug-naïve schizophrenia (FES).
- To explore if FES represents an initial stage of the pathological biochemical status seen in chronic schizophrenia.
Main Methods:
- Assessed platelet monoamine oxidase (MAO) and serum semicarbazide-sensitive amine oxidase (SSAO) activities.
- Measured serum middle-mass endotoxic molecules (MMEM) and malondialdehyde, alongside albumin functional parameters.
- Included 26 FES patients and 15 healthy controls.
Main Results:
- FES patients exhibited significantly increased MAO activity (99%) and MMEM concentration (124%), and decreased SSAO activity (26%) versus controls.
- Regression analysis revealed significant relationships between MAO, SSAO, MMEM, and Positive and Negative Syndrome Scale (PANNS) scores.
- Factor analysis grouped MAO and SSAO together, and MMEM with albumin parameters.
Conclusions:
- FES patients display a distinct metabolic profile characterized by altered enzyme activities and increased endotoxemia.
- The observed metabolic disturbances in FES suggest it is a precursor stage to the established pathological state in chronic schizophrenia.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Drug Therapy
Antianxiety Medications
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Psychological and Sociocultural Causes of Schizophrenia

